GANGLIOSIDE GD2 EXPRESSION IS MAINTAINED UPON RECURRENCE IN PATIENTS WITH OSTEOSARCOMA

被引：0
|
作者：
Poon, V., I [1 ,2 ]
Roth, M. [2 ]
Piperdi, S. [2 ]
Geller, D. [2 ]
Gill, J. [2 ]
Ridzinski, E. R. [3 ,4 ]
Hawkins, D. S. [3 ,4 ]
Gorlick, R. [1 ,2 ]
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[2] Albert Einstein Coll Med, Childrens Hosp Montefiore, Bronx, NY 10467 USA
[3] Fred Hutchinson Canc Res Ctr, Seattle Childrens Hosp, Seattle, WA 98104 USA
[4] Univ Washington, Seattle, WA 98195 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2015年 / 63卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
386
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [21] Ganglioside GD2 is not expressed by posterior uveal melanomas.
    Augsburger, JJ
    Foon, KA
    Chatterjec, M
    Schneider, S
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S384 - S384
  • [22] Ganglioside GD2 expression is significantly associated with unfavorable prognosis in triple negative breast cancer
    Saito, Kanako
    Higashi, Chihiro
    Kozuka, Yuji
    Yuasa, Hiroto
    Ishihara, Mikiya
    Mizuno, Toshiro
    Akahori, Yasushi
    Shiku, Hiroshi
    Tawara, Isao
    Ogawa, Tomoko
    Fujiwara, Hiroshi
    CANCER SCIENCE, 2023, 114 : 1583 - 1583
  • [23] Expression of Disialoganglioside GD2 in Neuroblastomas of Patients Treated with Immunotherapy
    Terzic, T.
    Teira, P.
    Cournoyer, S.
    Peuchmaur, M.
    Sartelet, H.
    LABORATORY INVESTIGATION, 2013, 93 : 449A - 449A
  • [24] Expression of Disialoganglioside GD2 in Neuroblastomas of Patients Treated with Immunotherapy
    Terzic, T.
    Teira, P.
    Cournoyer, S.
    Peuchmaur, M.
    Sartelet, H.
    MODERN PATHOLOGY, 2013, 26 : 449A - 449A
  • [25] DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses
    Bolesta, E
    Kowalczyk, A
    Wierzbicki, A
    Rotkiewicz, P
    Bambach, B
    Tsao, CY
    Horwacik, I
    Kolinski, A
    Rokita, H
    Brecher, M
    Wang, XH
    Ferrone, S
    Kozbor, D
    CANCER RESEARCH, 2005, 65 (08) : 3410 - 3418
  • [26] GD2 expression in breast cancer
    Orsi, Giulia
    Barbolini, Monica
    Ficarra, Guido
    Tazzioli, Giovanni
    Manni, Paola
    Petrachi, Tiziana
    Mastrolia, Ilenia
    Orvieto, Enrico
    Spano, Carlotta
    Prapa, Malvina
    Kaleci, Shaniko
    D'Amico, Roberto
    Guarneri, Valentina
    Dieci, Maria Vittoria
    Cascinu, Stefano
    Conte, Pierfranco
    Piacentini, Federico
    Dominici, Massimo
    ONCOTARGET, 2017, 8 (19) : 31592 - 31600
  • [27] ANTIBODY STRUCTURE STUDIES WITH MELANOMA-ASSOCIATED GD2 GANGLIOSIDE
    PICHLA, SL
    MURALI, R
    KORDOWICZ, M
    BURNETT, RM
    BIOPHYSICAL JOURNAL, 1993, 64 (02) : A57 - A57
  • [28] DETECTION OF GANGLIOSIDE GD2 IN TUMOR-TISSUES AND SERA OF NEURO-BLASTOMA PATIENTS
    SCHULZ, G
    CHERESH, DA
    VARKI, NM
    YU, A
    STAFFILENO, LK
    REISFELD, RA
    CANCER RESEARCH, 1984, 44 (12) : 5914 - 5920
  • [29] Expression of ganglioside GD2/GM2 synthase mRNA in mouse oocytes and early embryos.
    Kawachiya, S
    Kaneko, T
    Takahashi, T
    Seino, T
    Saito, H
    Kurachi, H
    FERTILITY AND STERILITY, 2001, 76 (03) : S212 - S212
  • [30] Chitosan nanoparticles targeted to the tumor-associated ganglioside GD2
    A. A. Zubareva
    A. A. Boyko
    I. V. Kholodenko
    F. N. Rozov
    M. V. Larina
    T. K. Aliev
    I. I. Doronin
    P. A. Vishnyakova
    I. M. Molotkovskaya
    R. V. Kholodenko
    Russian Journal of Bioorganic Chemistry, 2016, 42 : 532 - 545
12345